Generate Biomedicines
GENB
#5747
Rank
A$1.86 B
Marketcap
A$14.41
Share price
-8.00%
Change (1 day)
N/A
Change (1 year)

EPS for Generate Biomedicines (GENB)

EPS in 2026 (TTM): A-$4.08

According to Generate Biomedicines's latest financial reports the company's current EPS (TTM) is A-$4.13. In 2025 the company made an earnings per share (EPS) of A-$3.29 a decrease over its 2024 EPS that were of A-$3.16.

EPS history for Generate Biomedicines from 2024 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$4.0824%
2025A-$3.294.33%
2024A-$3.16